Stock listing

TPEx:6939 TFBS Bioscience, Inc. (啟弘生技) 股價

Follow TFBS Bioscience, Inc. into a list and get an email when it puts out news.

Share price · TPEX:6939

$18.45 TWD -1.30 (-6.6%)

Close on Nov 20, 2026

Past year -19.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$18.45 – $19.00 TWDNov 20, 2026
Volume
16,500 sharesNov 20, 2026
Market cap
$652.8M TWDAt the close on Nov 20, 2026 · price × 35.38M shares outstanding
52-week range
$17.10 – $27.85 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$592,633 TWDMedian day 15,530 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
TFBS Bioscience, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6939 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$18.45-1.30-6.6%$18.85$19.00$18.4516,500
$19.75+0.75+3.9%$19.75$19.75$19.751
$19.00+0.45+2.4%$19.15$19.80$19.0017,051
$18.55-0.10-0.5%$18.70$19.45$18.5535,021
$18.65+0.30+1.6%$18.50$18.65$18.501,010
$18.35-0.55-2.9%$18.85$19.10$18.0562,200
$18.90-0.50-2.6%$19.75$19.75$18.9012,003
$19.40+1.20+6.6%$18.20$19.60$18.2062,506
$18.20+0.05+0.3%$18.20$18.20$18.2050
$18.150.000.0%$17.50$18.15$17.1048,765
$18.15+0.15+0.8%$17.80$18.15$17.6040,002
$18.00-0.70-3.7%$18.70$18.70$17.8521,410
$18.700.000.0%$17.90$18.70$17.904,010
$18.70+0.05+0.3%$18.70$18.70$17.904,010
$18.650.000.0%$18.70$18.70$17.9011,020
$18.65+0.25+1.4%$18.15$18.65$17.959,005
$18.40+0.50+2.8%$17.90$18.70$17.9020,310
$17.90-0.90-4.8%$18.30$18.80$17.9020,090
$18.800.000.0%$18.80$18.80$18.800
$18.80+0.15+0.8%$18.65$19.20$18.6512,140
$18.650.000.0%$19.15$19.15$18.6511,030
$18.65+0.05+0.3%$17.95$19.25$17.9527,801
$18.60-0.45-2.4%$19.15$19.15$17.9561,201
$19.05-0.10-0.5%$19.50$20.60$18.45190,126
$19.15-0.15-0.8%$19.35$22.80$18.95342,905
$19.30+0.20+1.0%$19.10$19.65$18.9017,290
$19.10+0.05+0.3%$19.10$19.10$19.105,000
$19.05+0.10+0.5%$18.90$19.05$18.9029,001
$18.95-0.75-3.8%$19.00$19.10$18.9528,200
$19.70+0.70+3.7%$19.70$19.80$19.6016,030
$19.00-0.50-2.6%$19.85$19.85$19.001,001
$19.500.000.0%$20.00$20.00$19.3035,160
$19.500.000.0%$20.40$20.40$19.4029,019
$19.50-0.20-1.0%$19.50$19.50$19.501,000
$19.70+0.10+0.5%$19.70$19.90$19.5532,120
$19.60-0.95-4.6%$20.60$20.60$19.6015,030
$20.55+1.00+5.1%$20.30$20.55$19.859,021
$19.55+0.25+1.3%$19.40$19.85$19.2022,000
$19.30+1.10+6.0%$18.55$19.30$18.559,000
$18.20-2.00-9.9%$20.50$20.85$18.05149,569
$20.20-0.55-2.7%$20.20$20.20$20.201,501
$20.75+0.75+3.8%$20.00$20.85$19.9534,000
$20.000.000.0%$20.00$20.00$20.00100
$20.00+0.95+5.0%$20.00$20.00$19.106,495
$19.05-0.55-2.8%$19.80$19.80$19.056,020
$19.60-0.30-1.5%$20.00$20.05$19.3064,005
$19.90+0.80+4.2%$18.90$19.90$18.85132,770
$19.100.000.0%$18.90$19.10$18.906,000
$19.10-0.40-2.1%$19.10$19.30$19.0039,820
$19.50+0.40+2.1%$19.75$19.75$19.507,000
$19.10-0.10-0.5%$19.00$19.20$19.004,000
$19.20-0.60-3.0%$19.00$19.20$19.006,000
$19.80-0.05-0.3%$19.10$19.85$19.0012,100
$19.85+0.30+1.5%$19.85$19.85$19.853,100
$19.55-0.45-2.2%$19.00$19.55$19.0039,001
$20.00+0.25+1.3%$20.00$20.00$19.202,101
$19.75-0.30-1.5%$20.00$20.00$19.2050,470
$20.05-0.30-1.5%$19.60$20.80$19.6018,002
$20.35+0.70+3.6%$19.65$21.40$19.6556,379
$19.650.000.0%$19.65$19.65$19.651,500
$19.650.000.0%$19.65$19.65$19.651,500
$19.65+0.90+4.8%$19.65$19.65$19.651,000

Splits

1 split · TPEX:6939 · every price before a split is adjusted for it

DayRatioWhat
26-for-25Split
Ticker
TPEx:6939
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
TPEx
Currency
TWD

TFBS Bioscience, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services

Valuation

EV/sales 1.3× against a median of 2.2×: 4th lowest of 10 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$258.2M TWD
P/E
Loss
EV/sales
1.3×
EV/EBITDA
Negative EBITDA
Price/book
0.6×
Gross margin
19.1%
Operating margin
−40.4%
Net margin
−38.6%
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
TFBS Bioscience, Inc. · TPEX:6939US$19.81MUS$7.83Mn/a1.3×n/a0.6×−38.6%0.0×n/a
Biosino Bio-Technology & Science, Inc. Class H · HKEX:8247US$21.28MUS$19.44Mn/a0.7×n/a1.3×−27.8%0.1×n/a
GeneReach Biotechnology Corp. · TPEX:4171US$21.05MUS$9.04Mn/a1.3×222×1.2×−18.1%0.0×n/a
IVIM Technology, Inc. · KRX:460470US$20.68MUS$10.37Mn/a2.1×n/a1.1×−40.9%0.0×n/a
Q-linea AB · OMXSTO:QLINEAUS$20.66MUS$7.57Mn/a6.9×n/a0.9×n/a0.1×n/a
SANIGEN Co., Ltd. · KRX:188260US$19.66MUS$10.06Mn/a2.2×n/a2.3×−82.6%0.1×n/a
NanoRepro AG · XETR:NN6US$19.45MUS$11.45Mn/an/an/a0.5×n/a0.0×n/a
Urteste S.A. · GPW:URTUS$19.24MUS$19.10Mn/a3,525×n/a3.5×n/a0.0×n/a
Genematrix Inc. · KRX:109820US$19.06MUS$6.80Mn/a0.8×31.7×1.4×−1.7%0.0×n/a
Oxford BioDynamics PLC · LSE:OBDUS$18.46MUS$20.77Mn/a14.5×n/a4.3×n/a1.3×n/a
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S. · BIST:RTALBUS$18.41MUS$16.94M1.1×3.6×61.6×0.3×367.8%0.0×n/a
Median of the othersUS$19.56MUS$10.91M1.1×2.2×61.6×1.2×−22.9%0.0×

Team and board

Officers

OfficerRole
Tatung YuanChairman and Chief Executive Officer
Wilson LiaoChief Financial Officer
Seigyoku RyuVice President, TFBS BIOSCIENCE Japan
Chia-Hsin LiDirector, Testing Service Department
Esther ChiuSenior Manager, Quality Assurance department
Gabriel WuDirector, Manufacturing Department
Man-Shiow JiangChief Technology Officer
Shao-Hua LoDirector, Business Development Department

Board

DirectorRole
Tatung YuanChairman and Chief Executive Officer

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue193.1M180.6M231.9M252.7M160.9M118.6M
Cost of revenue156.3M143.0M168.6M148.7M106.8M84.0M
Gross profit36.8M37.5M63.3M104.0M54.0M34.6M
Research and development64.8M45.7M36.2M33.7M26.0M21.0M
Selling, general and administrative50.0M40.4M40.8M36.6M22.1M
Operating income-78.0M-61.2M-5.45M33.8M6.01M311.0K
Depreciation and amortization51.9M50.4M58.8M37.0M25.4M25.2M
EBITDA-26.1M-10.9M53.3M70.7M31.4M25.5M
Interest expense2.81M841.0K602.0K647.0K306.0K357.0K
Income before tax-73.9M-49.0M4.77M30.7M7.01M334.0K
Income tax-10.3M-135.0K3.02M886.0K38.0K
Net income-74.5M-38.7M4.91M27.7M6.12M296.0K
Earnings per share, basic-2.13-1.110.140.800.180.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents307.3M515.9M929.3M976.4M240.9M76.1M
Short-term investments133.5M178.0M50.0M50.0M
Receivables23.9M49.3M80.8M79.8M60.8M94.0K
Inventory13.9M12.9M8.84M5.69M5.86M
Current assets523.1M776.3M1.07B1.11B308.5M104.6M
Total assets1.46B1.50B1.45B1.36B491.3M288.4M
Accounts payable7.98M9.50M8.71M11.2M15.5M8.67M
Current liabilities200.3M188.7M84.9M103.8M50.5M26.6M
Total debt196.2M131.8M52.2M21.4M19.7M
Total liabilities294.7M265.1M187.4M126.2M66.4M40.4M
Shareholders' equity1.16B1.23B1.26B1.24B424.9M247.9M
Shares outstanding35.0M34.8M35.1M34.8M34.8M34.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-9.74M28.8M36.5M78.7M21.0M29.4M
Capital spending-225.4M-372.8M-55.9M-49.8M-19.0M-13.3M
Free cash flow-235.2M-344.0M-19.4M28.9M1.98M16.1M
Cash from investing-501.0M-57.6M-104.7M-19.4M-12.8M
Cash from financing60.5M-26.0M761.6M163.1M-6.87M
Dividends paid-1.74M-3.35M
Change in cash-208.6M-413.4M-47.1M735.5M164.8M9.77M

Open Financials

Cap table

Built by 6ix from TFBS Bioscience, Inc.’s releases

Common shares
35,384,161
Fully diluted
35,384,161

Fully diluted

LineShares
Common shares35,384,161

Share count over time

CountShares
Nov 22, 202635,384,161

Open Cap table

Shareholders

HolderSharesOf the companyAs of
台康生技股份有限公司4.94M14.0%Oct 31, 2026
致茂電子股份有限公司2.68M7.6%Oct 31, 2026
崇盛投資股份有限公司1.66M4.7%Oct 31, 2026
財團法人生物技術開發中心935K2.6%Oct 31, 2026
阮大同791K2.2%Oct 31, 2026
呂素卿119K0.34%Oct 31, 2026
吳沛宇74,8800.21%Oct 31, 2026
羅紹華56,5600.16%Oct 31, 2026
黃秀妙26,0000.07%Oct 31, 2026
廖秋坤2,000<0.01%Oct 31, 2026
All 16 holders
HolderSharesOf the companyAs of
劉永生00.00%Oct 31, 2026
江滿秀00.00%Oct 31, 2026
王柏森00.00%Oct 31, 2026
黃千岳00.00%Oct 31, 2026
林桓志00.00%Oct 31, 2026
張志榮00.00%Oct 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chia-Hsin LiDirector, Testing Service Department · Since at least Nov 5, 2026
Esther ChiuSenior Manager, Quality Assurance department · Since at least Nov 5, 2026
Gabriel WuDirector, Manufacturing Department · Since at least Nov 5, 2026
Man-Shiow JiangChief Technology Officer · Since at least Nov 5, 2026
Seigyoku RyuVice President, TFBS BIOSCIENCE Japan · Since at least Nov 5, 2026
Shao-Hua LoDirector, Business Development Department · Since at least Nov 5, 2026
Tatung YuanChairman and Chief Executive Officer · Since at least Nov 5, 2026
Wilson LiaoChief Financial Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about TFBS Bioscience, Inc.